AAAAAA

   
Results: 1-15 |
Results: 15
HOW CA-125 IS USED IN THE ROUTINE FOLLOW-UP OF OVARIAN-CANCER - A SURVEY OF 29 ITALIAN HOSPITALS
Authors: GION M BARIOLI P PONTI A TORRI V MIONE R DITTADI R
Citation: M. Gion et al., HOW CA-125 IS USED IN THE ROUTINE FOLLOW-UP OF OVARIAN-CANCER - A SURVEY OF 29 ITALIAN HOSPITALS, Tumor biology, 19(4), 1998, pp. 269-274
TISSUE POLYPEPTIDE ANTIGEN AS A PUTATIVE INDICATOR OF APOPTOSIS
Authors: DITTADI R CORADINI D MEO S PIRRONELLO E DAIDONE MG GION M
Citation: R. Dittadi et al., TISSUE POLYPEPTIDE ANTIGEN AS A PUTATIVE INDICATOR OF APOPTOSIS, Clinical chemistry, 44(9), 1998, pp. 2002-2003
PROGNOSTIC-SIGNIFICANCE OF VASCULAR ENDOTHELIAL GROWTH-FACTOR PROTEININ NODE-NEGATIVE BREAST-CARCINOMA
Authors: GASPARINI G TOI M GION M VERDERIO P DITTADI R HANATANI M MATSUBARA I VINANTE O BONOLDI E BORACCHI P GATTI C SUZUKI H TOMINAGA T
Citation: G. Gasparini et al., PROGNOSTIC-SIGNIFICANCE OF VASCULAR ENDOTHELIAL GROWTH-FACTOR PROTEININ NODE-NEGATIVE BREAST-CARCINOMA, Journal of the National Cancer Institute, 89(2), 1997, pp. 139-147
HIGH-TITER HER-2 NEU PROTEIN-SPECIFIC ANTIBODY CAN BE DETECTED IN PATIENTS WITH EARLY-STAGE BREAST-CANCER/
Authors: DISIS ML PUPA SM GRALOW JR DITTADI R MENARD S CHEEVER MA
Citation: Ml. Disis et al., HIGH-TITER HER-2 NEU PROTEIN-SPECIFIC ANTIBODY CAN BE DETECTED IN PATIENTS WITH EARLY-STAGE BREAST-CANCER/, Journal of clinical oncology, 15(11), 1997, pp. 3363-3367
QUANTITATIVE CHEMILUMINESCENT IMMUNOASSAY OF P53 - PROGNOSTIC-SIGNIFICANCE IN 220 NODE-NEGATIVE BREAST-CANCER TISSUE
Authors: DITTADI R BRAZZALE A MIONE R DIFRESCO S GATTI C VINANTE O BASSAN F NASCIMBEN O GION M
Citation: R. Dittadi et al., QUANTITATIVE CHEMILUMINESCENT IMMUNOASSAY OF P53 - PROGNOSTIC-SIGNIFICANCE IN 220 NODE-NEGATIVE BREAST-CANCER TISSUE, Anticancer research, 17(6D), 1997, pp. 4691-4696
ERBB2 ASSAY IN BREAST-CANCER - POSSIBLY IMPROVED CLINICAL INFORMATIONUSING A QUANTITATIVE METHOD
Authors: DITTADI R BRAZZALE A PAPPAGALLO G SALBE C NASCIMBEN O ROSABIAN A GION M
Citation: R. Dittadi et al., ERBB2 ASSAY IN BREAST-CANCER - POSSIBLY IMPROVED CLINICAL INFORMATIONUSING A QUANTITATIVE METHOD, Anticancer research, 17(2B), 1997, pp. 1245-1247
DETECTION OF DIFFERENT ESTROGEN-RECEPTOR FORMS IN BREAST-CANCER CYTOSOL BY ENZYME-IMMUNOASSAY
Authors: DITTADI R MEO S AMOROSO B GION M
Citation: R. Dittadi et al., DETECTION OF DIFFERENT ESTROGEN-RECEPTOR FORMS IN BREAST-CANCER CYTOSOL BY ENZYME-IMMUNOASSAY, Cancer research, 57(6), 1997, pp. 1066-1072
C-ERBB-2 NEU PROTEIN EXPRESSION, DNA-PLOIDY AND S-PHASE IN BREAST-CANCER/
Authors: DITTADI R CALDERAZZO F CABRELLE A DIFRESCO S GION M CHIECOBIANCHI L
Citation: R. Dittadi et al., C-ERBB-2 NEU PROTEIN EXPRESSION, DNA-PLOIDY AND S-PHASE IN BREAST-CANCER/, Cell proliferation, 29(7), 1996, pp. 403-412
DYNAMIC USE OF TUMOR-MARKERS, RATIONALE CLINICAL-APPLICATIONS AND PITFALLS
Authors: GION M MIONE R BARIOLI P DITTADI R
Citation: M. Gion et al., DYNAMIC USE OF TUMOR-MARKERS, RATIONALE CLINICAL-APPLICATIONS AND PITFALLS, Anticancer research, 16(4B), 1996, pp. 2279-2284
DETERMINATION OF ERBB2 PROTEIN IN BREAST-CANCER TISSUES BY DIFFERENT METHODS - RELATIONSHIPS WITH OTHER BIOLOGICAL PARAMETERS
Authors: PIFFANELLI A DITTADI R CATOZZI L GION M CAPITANIO G GELLI MC BRAZZALE A MALAGUTTI R PELIZZOLA D MENEGON A GIOVANNINI G GARDINI G
Citation: A. Piffanelli et al., DETERMINATION OF ERBB2 PROTEIN IN BREAST-CANCER TISSUES BY DIFFERENT METHODS - RELATIONSHIPS WITH OTHER BIOLOGICAL PARAMETERS, Breast cancer research and treatment, 37(3), 1996, pp. 267-276
STANDARDIZATION OF ASSAY FOR CYTOKERATIN RELATED TUMOR-MARKER CYFRA21.1 IN URINE SAMPLES
Authors: DITTADI R BARIOLI P GION M MIONE R BARICHELLO M CAPITANIO G COCCO G CAZZOLATO G DEBLASI F PRATURLON S ANTINOZZI R GIANNEO E
Citation: R. Dittadi et al., STANDARDIZATION OF ASSAY FOR CYTOKERATIN RELATED TUMOR-MARKER CYFRA21.1 IN URINE SAMPLES, Clinical chemistry, 42(10), 1996, pp. 1634-1638
EPIDERMAL GROWTH-FACTOR RECEPTORS AND ERBB2 PROTEIN EXPRESSION IN ESOPHAGEAL CANCER AND NORMAL MUCOSA
Authors: DITTADI R RUOL A GION M SEGALIN A PANOZZO M BRAZZALE A MEO S ANCONA E PERACCHIA A
Citation: R. Dittadi et al., EPIDERMAL GROWTH-FACTOR RECEPTORS AND ERBB2 PROTEIN EXPRESSION IN ESOPHAGEAL CANCER AND NORMAL MUCOSA, Oncology Reports, 2(3), 1995, pp. 381-385
RELATIONSHIP BETWEEN CATHEPSIN-D AND OTHER PATHOLOGICAL AND BIOLOGICAL PARAMETERS IN 1752 PATIENTS WITH PRIMARY BREAST-CANCER
Authors: GION M MIONE R DITTADI R ROMANELLI M PAPPAGALLO L CAPITANIO G FRIEDE U BARBAZZA R VISONA A DANTE S
Citation: M. Gion et al., RELATIONSHIP BETWEEN CATHEPSIN-D AND OTHER PATHOLOGICAL AND BIOLOGICAL PARAMETERS IN 1752 PATIENTS WITH PRIMARY BREAST-CANCER, European journal of cancer, 31A(5), 1995, pp. 671-677
PRELIMINARY-RESULTS OF A PROSPECTIVE EVALUATION OF H-3 THYMIDINE LABELING INDEX IN GLIOMAS
Authors: FIORENTINO MV BRANDES A ZAMPIERI P DITTADI R GARDIMAN M SALBE C PISTORELLO M ALESSIO L GION M SCELZI E
Citation: Mv. Fiorentino et al., PRELIMINARY-RESULTS OF A PROSPECTIVE EVALUATION OF H-3 THYMIDINE LABELING INDEX IN GLIOMAS, European journal of cancer, 31A, 1995, pp. 272-272
COMPARISON BETWEEN WESTERN BLOTTING, IMMUNOHISTOCHEMICAL AND ELISA ASSAY FOR P185(NEU) QUANTITATION IN BREAST-CANCER SPECIMENS
Authors: DITTADI R CATOZZI L GION M BRAZZALE A CAPITANIO G GELLI MC MENEGON A GARDINI G MALAGUTTI R PIFFANELLI A
Citation: R. Dittadi et al., COMPARISON BETWEEN WESTERN BLOTTING, IMMUNOHISTOCHEMICAL AND ELISA ASSAY FOR P185(NEU) QUANTITATION IN BREAST-CANCER SPECIMENS, Anticancer research, 13(5C), 1993, pp. 1821-1824
Risultati: 1-15 |